MARKET

XRTX

XRTX

Xortx Therapeutics Inc
NASDAQ
0.9889
-0.0511
-4.91%
Opening 15:28 05/14 EDT
OPEN
1.010
PREV CLOSE
1.040
HIGH
1.010
LOW
0.9490
VOLUME
34.70K
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
0.8020
MARKET CAP
3.75M
P/E (TTM)
-0.8591
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XRTX last week (0505-0509)?
Weekly Report · 2d ago
Weekly Report: what happened at XRTX last week (0428-0502)?
Weekly Report · 05/05 11:12
XORTX Therapeutics Delays Yearly Report Filing
TipRanks · 05/01 12:28
XORTX Advances NDA Filing for Gout Treatment Following FDA Guidance
TipRanks · 04/30 11:31
BRIEF-XORTX Therapeutics Provides Update On FDA Type B Meeting Request
Reuters · 04/30 11:12
XORTX THERAPEUTICS INC - EXPECTS TO FILE GOUT NDA IN H1 2026
Reuters · 04/30 11:00
XORTX Secures European Patent for Gout and Kidney Disease Therapies
TipRanks · 04/28 11:29
Weekly Report: what happened at XRTX last week (0421-0425)?
Weekly Report · 04/28 11:21
More
About XRTX
More
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.
Recently
Symbol
Price
%Change

Webull offers XORTX Therapeutics Inc stock information, including NASDAQ: XRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XRTX stock methods without spending real money on the virtual paper trading platform.